Ventric Health

Ventric Health is a medical technology company focused on innovations in cardiovascular health. With roots in university research, the company aims to enhance the diagnosis and treatment of heart failure through non-invasive, data-driven tools. Their flagship product, Vivio®, is the first FDA-cleared device designed to indicate elevated left ventricular end diastolic pressure (LVEDP), a critical marker for heart failure. This device allows clinicians to detect heart failure earlier in primary care and home settings, facilitating timely interventions. Ventric Health primarily serves care teams managing at-risk populations, including primary care providers and value-based care organizations. Their solutions address the challenges of diagnosing heart failure, particularly for patients who may remain undiagnosed due to traditional methods being invasive and slow. By providing mobile and non-invasive tools, Ventric Health supports healthcare providers in delivering effective care, ultimately improving patient outcomes and reducing healthcare costs. The company is dedicated to transforming cardiovascular care through scientific innovation and collaboration with healthcare professionals.

• Employees 35
• Total Funding $2233000